152 related articles for article (PubMed ID: 28057744)
1. Hematopoiesis in patients with mature B-cell malignancies is deregulated even in patients with undetectable bone marrow involvement.
Maswabi BC; Molinsky J; Savvulidi F; Zikmund T; Prukova D; Tuskova D; Klanova M; Vockova P; Lateckova L; Sefc L; Zivny J; Trneny M; Klener P
Haematologica; 2017 Apr; 102(4):e152-e155. PubMed ID: 28057744
[No Abstract] [Full Text] [Related]
2. Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy.
Dahl M; Kristensen LS; Grønbæk K
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30134619
[TBL] [Abstract][Full Text] [Related]
3. The tumor microenvironment shapes hallmarks of mature B-cell malignancies.
Shain KH; Dalton WS; Tao J
Oncogene; 2015 Sep; 34(36):4673-82. PubMed ID: 25639873
[TBL] [Abstract][Full Text] [Related]
4. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms.
Lesesve JF; Tardy S; Frotscher B; Latger-Cannard V; Feugier P; De Carvalho Bittencourt M
Int J Lab Hematol; 2015 Aug; 37(4):486-94. PubMed ID: 25470765
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal localization of DNA methylation in small B-cell lymphoma.
Taylor KH; Rahmatpanah F; Davis JW; Caldwell CW
Leukemia; 2008 Mar; 22(3):638-41. PubMed ID: 17728784
[No Abstract] [Full Text] [Related]
6. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
7. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
Huh YO; Keating MJ; Saffer HL; Jilani I; Lerner S; Albitar M
Am J Clin Pathol; 2001 Sep; 116(3):437-43. PubMed ID: 11554173
[TBL] [Abstract][Full Text] [Related]
8. CD117 expression in diffuse large B-cell lymphomas: fact or fiction?
Vakiani E; Cattoretti G; Colovai AI; Murty VV; Alobeid B; Bhagat G
Pathol Int; 2005 Nov; 55(11):716-23. PubMed ID: 16271084
[TBL] [Abstract][Full Text] [Related]
9. [Application of gene expression profiling in molecular classification, prognosis and therapy of B-cell lymphoma].
Mao ZR; Zhou R; Zhang XX; Mueller-Hermelink Hk; Rosenwald A
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):785-9. PubMed ID: 20079025
[No Abstract] [Full Text] [Related]
10. Bone Marrow Lymphoid Niche Adaptation to Mature B Cell Neoplasms.
Dumontet E; Mancini SJC; Tarte K
Front Immunol; 2021; 12():784691. PubMed ID: 34956214
[TBL] [Abstract][Full Text] [Related]
11. [Expression of Sox11 transcription factor in different types of B-cell lymphomas].
Zhang WM; Wang C; Li BZ
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):698-9. PubMed ID: 22321551
[No Abstract] [Full Text] [Related]
12. Follicular lymphoma with progression to diffuse large B-cell lymphoma and concurrent CD5-negative mantle cell lymphoma-3 entities in a lymph node.
Trimaldi JA; Bowers JW; Bello C; Sagatys EM
Cancer Control; 2014 Jul; 21(3):251-4. PubMed ID: 24955711
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression in B-cell lymphomas.
Gladkikh A; Potashnikova D; Korneva E; Khudoleeva O; Vorobjev I
Exp Hematol; 2010 Nov; 38(11):1047-57. PubMed ID: 20727381
[TBL] [Abstract][Full Text] [Related]
14. Chronic B cell malignancies and bone marrow microenvironment.
Ghia P; Granziero L; Chilosi M; Caligaris-Cappio F
Semin Cancer Biol; 2002 Apr; 12(2):149-55. PubMed ID: 12027587
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].
Chen ZY; Zhou XY; Zhang TM; Hong XN; Yin JL; Hu XC; Shi DR
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):183-8. PubMed ID: 19615255
[TBL] [Abstract][Full Text] [Related]
16. Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia.
Farfsing A; Engel F; Seiffert M; Hartmann E; Ott G; Rosenwald A; Stilgenbauer S; Döhner H; Boutros M; Lichter P; Pscherer A
Leukemia; 2009 Nov; 23(11):2018-26. PubMed ID: 19641524
[TBL] [Abstract][Full Text] [Related]
17. [Histologic evaluation of malignant lymphoma].
Li XQ
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):217-9. PubMed ID: 21615993
[No Abstract] [Full Text] [Related]
18. Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.
Yu W; Denu RA; Krautkramer KA; Grindle KM; Yang DT; Asimakopoulos F; Hematti P; Denu JM
J Biol Chem; 2016 Feb; 291(7):3268-79. PubMed ID: 26631723
[TBL] [Abstract][Full Text] [Related]
19. [Update knowledge about the classification of lymphomas].
Li XQ
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):577-9. PubMed ID: 24314240
[No Abstract] [Full Text] [Related]
20. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]